Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects.
This manuscript addresses how developing countries can maximize access to essential medicines and minimize unwanted side-effects within the legal environment of a compulsory license regime. While compulsory licensing can play a role in improving public health, external social and political conditions must be considered in order to make licensing an effective practice.
Bird
Robert C
RC
University of Connecticut School of Business, USA.
D000328:Adult; D002648:Child; D003906:Developing Countries / Q000191:economics; D016527:Drug Costs / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000191:economics / Q000941:ethics / Q000331:legislation & jurisprudence; D004335:Drug and Narcotic Control / Q000191:economics* / Q000331:legislation & jurisprudence / Q000639:trends; D018954:Drugs, Essential / Q000191:economics / Q000600:supply & distribution*; D006297:Health Services Accessibility / Q000191:economics / Q000941:ethics / Q000331:legislation & jurisprudence; D006801:Humans; D007391:International Cooperation / Q000331:legislation & jurisprudence; D037141:Mandatory Programs / Q000331:legislation & jurisprudence; D010330:Patents as Topic / Q000941:ethics / Q000331:legislation & jurisprudence*
D018954:Drugs, Essential